Resource Library
We’ve compiled a useful collection of resources to learn more about Medrio and various aspects of managing your clinical trial in today’s complex and evolving environment.
Success Story
CDMS / EDC
The Right EDC Gives Paragonix Technologies Ultimate Autonomy with a Lean Team
Paragonix Technologies selected Medrio EDC for their GUARDIAN-HEART clinical study. Electronic Data Capture (EDC) technology is being used to collect and manage registry data, examining the effect of controlled hypothermic...
Success Story
DCT•eConsent
TargetCancer Foundation Successfully Engages and Empowers Rare Cancer Patients with Medrio
TargetCancer Foundation implemented Medrio’s remote consent function in their TCF-001 TRACK study, which has an objective to determine if rare tumors can benefit from matched molecular therapy. The study is...
White Paper
CDMS / EDC•eCOA / ePRO•eConsent•eSource
Patient Engagement Guide for Sponsors and CROs
Now, more than ever, sponsors and CROs need to prioritize including patient engagement in their study builds from the ground-up. This involves defining processes to remove barriers for access, increasing awareness and education for clinical trials, and creating effective exchanges between patients and their clinicians.
White Paper
RTSM
How Sponsors Can Achieve Operational Efficiency with RTSM
When your trials rely on an investigational product (IP), your study timeline, budget, and overall success are closely tied to having the right product available at the right time and site. Once randomization is added in, sponsors can struggle to maintain an increasingly complex supply chain. Achieve operational efficiency with RTSM.
White Paper
DCT
The Rise of Hybrid Trials
Are your clinical trials equipped for a modern world? Prior to 2020, the answer was likely not very much.
White Paper
eConsent
Your Consent Can Make or Break Your Studies
Disruptions due to COVID-19 paired with a slew of new guidance from regulatory bodies has catapulted the clinical trial industry into a period of digital transformation.1 More sponsors and CROs are beginning to adopt decentralized solutions and embrace digital workflows, yet informed consent continues to rely heavily on paper-based processes. Lots and lots of paper.